Cite
HARVARD Citation
Morris, V. et al. (n.d.). Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet oncology. 18 (4), pp. 446-453. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morris, V. et al. (n.d.). Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet oncology. 18 (4), pp. 446-453. [Online].